The global apoptosis assays market is witnessing rapid growth, driven by the increasing demand for innovative assay kits, advancements in radionuclide tracers, and expanding applications in drug discovery and clinical research. Valued at US$ 4.6 billion in 2023, the market is projected to reach US$ 11.3 billion by 2034, growing at a robust CAGR of 8.5% during the forecast period. Apoptosis, or...